KRAS mutant gastric tumor samples (TCGA-STAD) also showed significantly higher expression of CCNA2 (p = 4.76 × 10−4 by Wilcoxon test) than wild-type gastric tumors (Figure 4a). The gene discussed is KRAS; the disease is gastric neoplasm.